{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:07:38Z","timestamp":1794625658003,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>MRI is an integral part of breast cancer screening in high-risk patients. We investigated whether the application of the Kaiser score, a clinical decision-support tool, may be used to exclude malignancy in contrast-enhancing lesions classified as BI-RADS 4 on breast MRI screening exams.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 183 consecutive, histologically proven, suspicious (MR BI-RADS 4) lesions detected within our local high-risk screening program. All lesions were evaluated according to the Kaiser score for breast MRI by three readers blinded to the final histopathological diagnosis. The Kaiser score ranges from 1 (lowest, cancer very unlikely) to 11 (highest, cancer very likely) and reflects increasing probabilities of malignancy, with scores greater than 4 requiring biopsy. Receiver operating characteristic (ROC) curve analysis was used to evaluate diagnostic accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 142 benign and 41 malignant lesions, diagnosed in 159 patients (mean age, 43.6 years). Median Kaiser scores ranged between 2 and 5 in benign and 7 and 8 in malignant lesions. For all lesions, the Kaiser score\u2019s accuracy, represented by the area under the curve (AUC), ranged between 86.5 and 90.2. The sensitivity of the Kaiser score was high, between 95.1 and 97.6% for all lesions, and was best in mass lesions. Application of the Kaiser score threshold for malignancy (\u2264 4) could have potentially avoided 64 (45.1%) to 103 (72.5%) unnecessary biopsies in 142 benign lesions previously classified as BI-RADS 4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The use of Kaiser score in high-risk MRI screening reliably excludes malignancy in more than 45% of contrast-enhancing lesions classified as BI-RADS 4.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      \u2022\n                      <jats:italic>The Kaiser score shows high diagnostic accuracy in identifying malignancy in contrast-enhancing lesions in patients undergoing high-risk screening for breast cancer.<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      \u2022\n                      <jats:italic>The application of the Kaiser score may avoid &gt; 45% of unnecessary breast biopsies in high-risk patients.<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      \u2022\n                      <jats:italic>The Kaiser score aids decision-making in high-risk breast cancer MRI screening programs.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-020-06945-z","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T21:02:12Z","timestamp":1591390932000},"page":"6052-6061","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams"],"prefix":"10.1007","volume":"30","author":[{"given":"Ruxandra Iulia","family":"Milos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pipan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Kalovidouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Clauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Kapetas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bernathova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Helbich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-5398","authenticated-orcid":false,"given":"Pascal A. T.","family":"Baltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,6]]},"reference":[{"key":"6945_CR1","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1200\/JCO.2007.15.2108","volume":"26","author":"N Houssami","year":"2008","unstructured":"Houssami N, Ciatto S, Macaskill P et al (2008) Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26:3248\u20133258","journal-title":"J Clin Oncol"},{"key":"6945_CR2","doi-asserted-by":"publisher","first-page":"20160715","DOI":"10.1259\/bjr.20160715","volume":"90","author":"K Pinker","year":"2017","unstructured":"Pinker K, Helbich TH, Morris EA (2017) The potential of multiparametric MRI of the breast. Br J Radiol 90:20160715","journal-title":"Br J Radiol"},{"key":"6945_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.7326\/0003-4819-148-9-200805060-00007","volume":"148","author":"E Warner","year":"2008","unstructured":"Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148:671\u2013679","journal-title":"Ann Intern Med"},{"key":"6945_CR4","doi-asserted-by":"crossref","unstructured":"Bennani-Baiti B, Baltzer PA (2017) MR imaging for diagnosis of malignancy in mammographic microcalcifications: a systematic review and meta-analysis. Radiology 283:692\u2013701","DOI":"10.1148\/radiol.2016161106"},{"key":"6945_CR5","doi-asserted-by":"publisher","first-page":"e0160346","DOI":"10.1371\/journal.pone.0160346","volume":"11","author":"B Bennani-Baiti","year":"2016","unstructured":"Bennani-Baiti B, Bennani-Baiti N, Baltzer PA (2016) Diagnostic performance of breast magnetic resonance imaging in non-calcified equivocal breast findings: results from a systematic review and meta-analysis. PLoS One 11:e0160346","journal-title":"PLoS One"},{"key":"6945_CR6","doi-asserted-by":"publisher","unstructured":"Mann RM, Kuhl CK, Moy L (2019) Contrast-enhanced MRI for breast cancer screening. J Magn Reson Imaging 50(2):377\u2013390. https:\/\/doi.org\/10.1002\/jmri.26654","DOI":"10.1002\/jmri.26654"},{"key":"6945_CR7","unstructured":"(2013) Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. National Collaborating Centre for Cancer (UK), Cardiff (UK). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK247567\/"},{"key":"6945_CR8","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s00330-015-3807-z","volume":"25","author":"RM Mann","year":"2015","unstructured":"Mann RM, Balleyguier C, Baltzer PA et al (2015) Breast MRI: EUSOBI recommendations for women\u2019s information. Eur Radiol 25:3669\u20133678","journal-title":"Eur Radiol"},{"key":"6945_CR9","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1200\/JCO.2014.56.8626","volume":"33","author":"CC Riedl","year":"2015","unstructured":"Riedl CC, Luft N, Bernhart C et al (2015) Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol 33:1128\u20131135","journal-title":"J Clin Oncol"},{"key":"6945_CR10","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317\u20131325","journal-title":"JAMA"},{"key":"6945_CR11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00330-006-0389-9","volume":"17","author":"F Sardanelli","year":"2007","unstructured":"Sardanelli F, Podo F (2007) Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection? Eur Radiol 17:873\u2013887","journal-title":"Eur Radiol"},{"key":"6945_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1148\/radiol.2461062173","volume":"246","author":"S Schrading","year":"2008","unstructured":"Schrading S, Kuhl CK (2008) Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology 246:58\u201370","journal-title":"Radiology"},{"key":"6945_CR13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1148\/radiol.2522081032","volume":"252","author":"FJ Gilbert","year":"2009","unstructured":"Gilbert FJ, Warren RM, Kwan-Lim G et al (2009) Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features. Radiology 252:358\u2013368","journal-title":"Radiology"},{"key":"6945_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejrad.2018.07.026","volume":"106","author":"MA Marino","year":"2018","unstructured":"Marino MA, Riedl CC, Bernathova M et al (2018) Imaging phenotypes in women at high risk for breast cancer on mammography, ultrasound, and magnetic resonance imaging using the fifth edition of the breast imaging reporting and data system. Eur J Radiol 106:150\u2013159","journal-title":"Eur J Radiol"},{"key":"6945_CR15","volume-title":"ACR BI-RADS\u00ae atlas, breast imaging reporting and data system","author":"CJ D\u2019Orsi","year":"2013","unstructured":"D\u2019Orsi CJ, Sickles EA, Mendelson EB, Morris EA et al (2013) ACR BI-RADS\u00ae atlas, breast imaging reporting and data system. Reston, American College of Radiology"},{"key":"6945_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s13244-018-0611-8","volume":"9","author":"M Dietzel","year":"2018","unstructured":"Dietzel M, Baltzer PAT (2018) How to use the Kaiser score as a clinical decision rule for diagnosis in multiparametric breast MRI: a pictorial essay. Insights Imaging 9:325\u2013335","journal-title":"Insights Imaging"},{"key":"6945_CR17","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00330-013-2804-3","volume":"23","author":"PA Baltzer","year":"2013","unstructured":"Baltzer PA, Dietzel M, Kaiser WA (2013) A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography. Eur Radiol 23:2051\u20132060","journal-title":"Eur Radiol"},{"key":"6945_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00508-015-0880-x","volume":"127","author":"CF Singer","year":"2015","unstructured":"Singer CF, Tea MK, Pristauz G et al (2015) Clinical practice guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families. Wien Klin Wochenschr 127:981\u2013986","journal-title":"Wien Klin Wochenschr"},{"key":"6945_CR19","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.1158\/1078-0432.CCR-07-1270","volume":"13","author":"CC Riedl","year":"2007","unstructured":"Riedl CC, Ponhold L, Flory D et al (2007) Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 13:6144\u20136152","journal-title":"Clin Cancer Res"},{"key":"6945_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1055\/s-0032-1322733","volume":"33","author":"M Hahn","year":"2012","unstructured":"Hahn M, Krainick-Strobel U, Toellner T et al (2012) Interdisciplinary consensus recommendations for the use of vacuum-assisted breast biopsy under sonographic guidance: first update 2012. Ultraschall Med 33:366\u2013371","journal-title":"Ultraschall Med"},{"key":"6945_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ejrad.2008.07.010","volume":"72","author":"SH Heywang-Kobrunner","year":"2009","unstructured":"Heywang-Kobrunner SH, Sinnatamby R, Lebeau A et al (2009) Interdisciplinary consensus on the uses and technique of MR-guided vacuum-assisted breast biopsy (VAB): results of a European consensus meeting. Eur J Radiol 72:289\u2013294","journal-title":"Eur J Radiol"},{"key":"6945_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0720-048X(02)00196-1","volume":"47","author":"SH Heywang-Kobrunner","year":"2003","unstructured":"Heywang-Kobrunner SH, Schreer I, Decker T, Bocker W (2003) Interdisciplinary consensus on the use and technique of vacuum-assisted stereotactic breast biopsy. Eur J Radiol 47:232\u2013236","journal-title":"Eur J Radiol"},{"key":"6945_CR23","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1102\/1470-7330.2012.0047","volume":"12","author":"C Zhang","year":"2012","unstructured":"Zhang C, Lewis DR, Nasute P, Hayes M, Warren LJ, Gordon PB (2012) The negative predictive value of ultrasound-guided 14-gauge core needle biopsy of breast masses: a validation study of 339 cases. Cancer Imaging 12:488\u2013496","journal-title":"Cancer Imaging"},{"key":"6945_CR24","first-page":"219","volume-title":"European guidelines for quality assurance in breast cancers screening and diagnosis","year":"2006","unstructured":"Perry NBM, de Wolf C, T\u00f6rnberg S, Holland R, von Karsa L, Puthaar E (eds) (2006) European guidelines for quality assurance in breast cancers screening and diagnosis, 4th edn. Office for Official Publications of the European Communities, Luxembourg, pp 219\u2013255","edition":"4"},{"key":"6945_CR25","first-page":"219","volume-title":"Quality assurance guidelines for pathology in European guidelines for quality assurance in breast cancers screening and diagnosis","year":"2006","unstructured":"Perry NBM, de Wolf C, T\u00f6rnberg S, Holland R, von Karsa L, Puthaar E (eds) (2006) Quality assurance guidelines for pathology in European guidelines for quality assurance in breast cancers screening and diagnosis, 4th edn. Office for Official Publications of the European Communities, Luxembourg, pp 219\u2013255","edition":"4"},{"key":"6945_CR26","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s00330-015-4075-7","volume":"26","author":"MA Marino","year":"2016","unstructured":"Marino MA, Clauser P, Woitek R et al (2016) A simple scoring system for breast MRI interpretation: does it compensate for reader experience? Eur Radiol 26:2529\u20132537","journal-title":"Eur Radiol"},{"key":"6945_CR27","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1007\/s00330-017-4755-6","volume":"27","author":"R Woitek","year":"2017","unstructured":"Woitek R, Spick C, Schernthaner M et al (2017) A simple classification system (the Tree flowchart) for breast MRI can reduce the number of unnecessary biopsies in MRI-only lesions. Eur Radiol 27:3799\u20133809","journal-title":"Eur Radiol"},{"key":"6945_CR28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00330-019-06444-w","volume":"30","author":"GJ Wengert","year":"2020","unstructured":"Wengert GJ, Pipan F, Almohanna J et al (2020) Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI. Eur Radiol 30:1451\u20131459","journal-title":"Eur Radiol"},{"key":"6945_CR29","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00330-017-5127-y","volume":"28","author":"C Spick","year":"2018","unstructured":"Spick C, Bickel H, Polanec SH, Baltzer PA (2018) Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis. Eur Radiol 28:1919\u20131928","journal-title":"Eur Radiol"},{"key":"6945_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427\u2013437","journal-title":"N Engl J Med"},{"key":"6945_CR31","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00330-008-0851-y","volume":"18","author":"J Veltman","year":"2008","unstructured":"Veltman J, Mann R, Kok T et al (2008) Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI. Eur Radiol 18:931\u2013938","journal-title":"Eur Radiol"},{"key":"6945_CR32","doi-asserted-by":"publisher","first-page":"20170441","DOI":"10.1259\/bjr.20170441","volume":"91","author":"CK Kuhl","year":"2018","unstructured":"Kuhl CK (2018) Abbreviated breast MRI for screening women with dense breast: the EA1141 trial. Br J Radiol 91:20170441","journal-title":"Br J Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-06945-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-020-06945-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-06945-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T19:23:14Z","timestamp":1622920994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-020-06945-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,6]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["6945"],"URL":"https:\/\/doi.org\/10.1007\/s00330-020-06945-z","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,6]]},"assertion":[{"value":"7 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Pascal A.T. Baltzer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The investigated patients are part of the national high-risk breast cancer screening program conducted at our institution. Several reports in other contexts (no overlap of rationale or results) have been published, the patient overlap of the more recent reports 1 and 2 is > 80%:Marino MA, Riedl CC, Bernathova M, et al (2018) Imaging phenotypes in women at high risk for breast cancer on mammography, ultrasound, and magnetic resonance imaging using the fifth edition of the breast imaging reporting and data system. Eur J Radiol 106:150\u2013159.\n                      \n                      Riedl CC, Luft N, Bernhart C, et al (2015) Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol 33:1128\u20131135.\n                      \n                      Riedl CC, Ponhold L, Fl\u00f6ry D, et al (2007) Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 13:6144\u20136152.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 retrospective\u2022 cross-sectional observational study\u2022 performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}